Evidence map›Paper›PMID 29858774›Full record

ArticleMolecular neurobiology2018

Docosanoids Promote Neurogenesis and Angiogenesis, Blood-Brain Barrier Integrity, Penumbra Protection, and Neurobehavioral Recovery After Experimental Ischemic Stroke.

Ludmila Belayev, Sung-Ha Hong, Hemant Menghani, Shawn J Marcell, Andre Obenaus, Raul S Freitas, Larissa Khoutorova, Veronica Balaszczuk, Bokkyoo Jun, Reinaldo B Oriá and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 2 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 2 syntheses or guidelines pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Omega-3 Polyunsaturated Fatty Acids and Stroke Burden.International journal of molecular sciences · 2019
    Pooled it
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Impacts of Oxylipins on ischemic stroke: from pathophysiology to clinical phenotypes.Metabolomics : Official journal of the Metabolomic Society · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Opto-Lipidomics of Tissues.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Ludmila BelayevNeuroscience Center of Excellence, School of Medicine, Louisiana State University Health New Orleans, 2020 Gravier St,, New Orleans, LA, 70112, USA. lbelay@lsuhsc.edu.ORCID http://orcid.org/0000-0001-8687-9340
Sung-Ha HongNeuroscience Center of Excellence, School of Medicine, Louisiana State University Health New Orleans, 2020 Gravier St,, New Orleans, LA, 70112, USA.
Hemant MenghaniNeuroscience Center of Excellence, School of Medicine, Louisiana State University Health New Orleans, 2020 Gravier St,, New Orleans, LA, 70112, USA.
Shawn J MarcellNeuroscience Center of Excellence, School of Medicine, Louisiana State University Health New Orleans, 2020 Gravier St,, New Orleans, LA, 70112, USA.
Andre ObenausDepartment of Pediatrics, University of California, Irvine, Irvine, CA, 92697, USA.
Raul S FreitasNeuroscience Center of Excellence, School of Medicine, Louisiana State University Health New Orleans, 2020 Gravier St,, New Orleans, LA, 70112, USA.
Larissa KhoutorovaNeuroscience Center of Excellence, School of Medicine, Louisiana State University Health New Orleans, 2020 Gravier St,, New Orleans, LA, 70112, USA.
Veronica BalaszczukNeuroscience Center of Excellence, School of Medicine, Louisiana State University Health New Orleans, 2020 Gravier St,, New Orleans, LA, 70112, USA.
Bokkyoo JunNeuroscience Center of Excellence, School of Medicine, Louisiana State University Health New Orleans, 2020 Gravier St,, New Orleans, LA, 70112, USA.
Reinaldo B OriáNeuroscience Center of Excellence, School of Medicine, Louisiana State University Health New Orleans, 2020 Gravier St,, New Orleans, LA, 70112, USA.
Nicolas G BazanNeuroscience Center of Excellence, School of Medicine, Louisiana State University Health New Orleans, 2020 Gravier St,, New Orleans, LA, 70112, USA.
Louisiana State University Health Sciences Center New Orleans · USUniversidade Federal do Ceará · BRChildren's Hospital of New Orleans · USThe University of Texas Health Science Center · USUniversity of California, Irvine · US

Funding

Multiphoton ConfocalP30GM103340 · NIGMS · LSU HEALTH SCIENCES CENTER · PI SHELINE, CHRISTIAN THOMAS · 2012 to 2016
$5.1M
Neuroprotection Lipid Signaling in Ischemia ReperfusionR01NS046741 · NINDS · LSU HEALTH SCIENCES CENTER · PI BAZAN, NICOLAS G. · 2004 to 2014
$3.4M
Novel combinatory therapy for experimental ischemic strokeR01NS104117 · NINDS · LSU HEALTH SCIENCES CENTER · PI BAZAN, NICOLAS G., BELAYEV, LUDMILA S. · 2018 to 2022
$1.6M
Neuroprotection by Docosahexaenoic Acid-Albumin in Experimental StrokeR01NS065786 · NINDS · LSU HEALTH SCIENCES CENTER · PI BELAYEV, LUDMILA S. · 2010 to 2014
$1.6M
National Institute of General Medical Sciences (US) GM103340National Institute of Neurological Disorders and Stroke NS046741NIGMS NIH HHS P30 GM103340NINDS NIH HHS R01 NS046741NINDS NIH HHS R01 NS065786NINDS NIH HHS R01 NS104117
6 · The paper itself

Abstract

Docosahexaenoic acid (DHA) and neuroprotectin D1 (NPD1) are neuroprotective after experimental ischemic stroke. To explore underlying mechanisms, SD rats underwent 2 h of middle cerebral artery occlusion (MCAo) and treated with DHA (5 mg/kg, IV) or NPD1 (5 μg/per rat, ICV) and vehicles 1 h after. Neuro-behavioral assessments was conducted on days 1, 2, and 3, and on week 1, 2, 3, or 4. BrdU was injected on days 4, 5, and 6, immunohistochemistry was performed on week 2 or 4, MRI on day 7, and lipidomic analysis at 4 and 5 h after onset of stroke. DHA improved short- and long-term behavioral functions and reduced cortical, subcortical, and total infarct volumes (by 42, 47, and 31%, respectively) after 2 weeks and reduced tissue loss by 50% after 4 weeks. DHA increased the number of BrdU

Indexed as

Behavior, AnimalNeovascularization, PhysiologicNeurogenesisAnimalsAxonsBlood-Brain BarrierBrain IschemiaDocosahexaenoic AcidsDoublecortin ProteinFatty AcidsInfarction, Middle Cerebral ArteryMaleNerve RegenerationPermeabilityRats, Sprague-DawleyStrokebehenic acidDcx protein, ratDocosahexaenoic AcidsDoublecortin ProteinFatty Acidsprotectin D1BBBBehaviorMRINeuroprotectionOmega-3 fatty acids

Identifiers

PMID29858774
PMCPMC6054805
OpenAlexW2807382073

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.